Abstract:BackgroundGrowing evidence suggests that hepatitis C virus (HCV) contributes to hepatocellular carcinoma (HCC) by directly modulating oncogenic signaling pathways. Protein phosphatase magnesium-dependent 1A (PPM1A) has recently emerged as an important tumor suppressor as it can block a range of tumor-centric signaling pathways through protein dephosphorylation. However, the role and regulatory mechanisms of PPM1A in HCV-infected cells have not been reported.MethodsTotal, cytoplasmic, and nuclear PPM1A protein after HCV infection or overexpression of HCV nonstructural protein 3 (NS3) were detected by western blotting. The expression of PPM1A in normal liver and HCV-related HCC tissues was quantified by immunohistochemistry. The effects of HCV infection and NS3 expression on the PPM1A protein level were systematically analyzed, and the ubiquitination level of PPM1A was determined by precipitation with anti-PPM1A and immunoblotting with either anti-ubiquitin or anti-PPM1A antibody. Finally, the roles of NS3 and PPM1A in hepatoma cell migration and invasion were assessed by wound healing and transwell assays, respectively.ResultsHCV infection and replication decreased PPM1A abundance, mediated by NS3, in hepatoma cells. Compared to normal liver tissues, the expression of PPM1A was significantly decreased in the HCC tumor tissues and adjacent non-tumor tissues. NS3 directly interacted with PPM1A to promote PPM1A ubiquitination and degradation, which was dependent on its protease domain. Blockade of PPM1A through small interfering RNA significantly promoted HCC cell migration, invasion, and epithelial mesenchymal transition (EMT), which were further intensified by TGF-β1 stimulation, in vitro. Furthermore, restoration of PPM1A abrogated the NS3-mediated promotion of HCC migration and invasion to a great extent, which was dependent on its protein phosphatase function.ConclusionsOur findings demonstrate that the HCV protein NS3 can downregulate PPM1A by promoting its ubiquitination and proteasomal degradation, which might contribute to the migration and invasion of hepatoma cells and may represent a new strategy of HCV in carcinogenesis.

Downregulation of a mitochondrial micropeptide, MPM, promotes hepatoma metastasis by enhancing mitochondrial complex I activity

Down-regulation of a Mitochondrial Micropeptide MPM Promotes Hepatoma Metastasis by Enhancing Mitochondrial Complex I Activity.

MNS1 Promotes Hepatocarcinogenesis and Metastasis Via Activating PI3K/AKT by Translocating Β‐catenin and Predicts Poor Prognosis

Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation

Downregulation of HNRNPM Inhibits Cell Proliferation and Migration of Hepatocellular Carcinoma Through MAPK/AKT Signaling Pathway

miR‐576‐3p/M‐phase phosphoprotein 8 axis regulates the malignant progression of hepatocellular carcinoma cells via the PI3K/Akt signaling pathway

MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.

MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.

Down-Regulation of Ndufb9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism

NMI Promotes Hepatocellular Carcinoma Progression Via BDKRB2 and MAPK/ERK Pathway

MTA1 Promotes Metastasis of MPM Via Suppression of E-cadherin

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

A novel mitochondrial micropeptide MPM enhances mitochondrial respiratory activity and promotes myogenic differentiation

Downregulated Mitochondrial Transcription Factor A Enhances Mycoplasma Infection to Promote the Metastasis of Hepatocellular Carcinoma.

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells.

Methylation-associated Silencing of Microrna-129-3p Promotes Epithelial-Mesenchymal Transition, Invasion and Metastasis of Hepatocelluar Cancer by Targeting Aurora-A.

Micropeptide MPM regulates cardiomyocyte proliferation and heart growth via the AKT pathway

Mir-106B-5p Promotes Stem Cell-Like Properties of Hepatocellular Carcinoma Cells by Targeting PTEN Via PI3K/Akt Pathway

DNA Methylation-Mediated Silencing of Matricellular Protein Dermatopontin Promotes Hepatocellular Carcinoma Metastasis by Α3β1 Integrin-Rho GTPase Signaling.

PNMA1, regulated by miR-33a-5p, promotes proliferation and EMT in hepatocellular carcinoma by activating the Wnt/β-catenin pathway.